91 related articles for article (PubMed ID: 1812039)
1. Immunohistochemical analysis of the expression of the c-myc oncoprotein in human stomach cancers.
Spandidos DA; Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK
Digestion; 1991; 50(3-4):127-34. PubMed ID: 1812039
[TBL] [Abstract][Full Text] [Related]
2. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
[TBL] [Abstract][Full Text] [Related]
3. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?
Nakayama T; Ling ZQ; Mukaisho K; Hattori T; Sugihara H
BMC Cancer; 2010 Jun; 10():311. PubMed ID: 20565940
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-myc mRNA as an aid in histologic differentiation of adenoma from well differentiated adenocarcinoma in the stomach.
Tatsuta M; Iishi H; Baba M; Nakaizumi A; Uehara H; Taniguchi H
Cancer; 1994 Apr; 73(7):1795-9. PubMed ID: 8137202
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].
Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785
[TBL] [Abstract][Full Text] [Related]
6. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach.
Lou L; Wang Y; Cui J; Yan X; Xue L; Li Y
Tumour Biol; 2014 May; 35(5):5029-36. PubMed ID: 24488669
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Ets-1 proto-oncogene in human gastric carcinoma: correlation with tumor invasion.
Nakayama T; Ito M; Ohtsuru A; Naito S; Nakashima M; Fagin JA; Yamashita S; Sekine I
Am J Pathol; 1996 Dec; 149(6):1931-9. PubMed ID: 8952528
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and cell proliferation in the development of gastric carcinomas: associations with c-myc and p53 protein expression.
Ishii HH; Gobé GC; Pan W; Yoneyama J; Ebihara Y
J Gastroenterol Hepatol; 2002 Sep; 17(9):966-72. PubMed ID: 12167117
[TBL] [Abstract][Full Text] [Related]
12. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
13. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
14. Amplification of the c-myc oncogene in human stomach cancers.
Nakasato F; Sakamoto H; Mori M; Hayashi K; Shimosato Y; Nishi M; Takao S; Nakatani K; Terada M; Sugimura T
Gan; 1984 Sep; 75(9):737-42. PubMed ID: 6500230
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Liu X; Yu H; Cai H; Wang Y
J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Iwatsuki M; Mimori K; Fukagawa T; Ishii H; Yokobori T; Sasako M; Baba H; Mori M
Ann Surg Oncol; 2010 Sep; 17(9):2526-33. PubMed ID: 20358301
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
[TBL] [Abstract][Full Text] [Related]
18. c-Myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer.
Han S; Kim HY; Park K; Cho HJ; Lee MS; Kim HJ; Kim YD
J Korean Med Sci; 1999 Oct; 14(5):526-30. PubMed ID: 10576148
[TBL] [Abstract][Full Text] [Related]
19. Expression of Bax protein in gastric carcinomas. A clinicopathological and immunohistochemical study.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Chalkley L; Karagiannis J; Paraskeva K; Mathou N; Dellaporta E; Tsianos E; Agnantis NJ
Acta Gastroenterol Belg; 2007; 70(3):285-9. PubMed ID: 18074738
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype.
Seo HM; Chang YS; Joo SH; Kim YW; Park YK; Hong SW; Lee SH
J Surg Oncol; 2009 Mar; 99(3):143-7. PubMed ID: 19117018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
